Pharmaceuticals - Community Register


Community list of not active veterinary medicinal products


Product information

Invented name: Nobivac Piro
Auth. number : EU/2/04/046
Active substance : 606 (301-911) total antigenic mass units of soluble parasite antigen (SPA) from Babesia canis and Babesia rossi cultures
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI07 - Immunologicals for canidae
Pharmacological subgroup: QI07A - Dog
Chemical subgroup: QI07AO - Inactivated parasitic vaccines
Chemical substance: QI07AO - Inactivated parasitic vaccines
(See WHO ATCvet Index)
Indication: For active immunisation of dogs of 6 months of age or older against Babesia canis to reduce the severity of clinical signs associated with acute Babesiosis (B. canis) and anaemia as measured by Packed Cell Volume (PCV).
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/09/2004 Centralised - Authorisation EMEA/V/C/84 (2004)3430 of 02/09/2004
04/11/2005 Centralised - Variation (no change in Commission Decision) EMEA/V/C/84/IB/1
12/02/2007 Centralised - Variation EMEA/V/C/84/IB/5
Updated with Decision(2007)1277 of 14/03/2007
20/02/2007 Centralised - Variation (no change in Commission Decision) EMEA/V/C/84/II/3
22/02/2007 Centralised - Variation EMEA/V/C/84/II/2 (2007)604 of 20/02/2007
16/03/2007 Centralised - Variation EMEA/V/C/84/II/4 (2007)1277 of 14/03/2007
21/07/2009 Centralised - Renewal EMEA/V/C/84/R/6 (2009)5835 of 16/07/2009
20/05/2010 Centralised - Variation (no change in Commission Decision) EMEA/V/C/84/IB/7
24/05/2013 Centralised - Withdrawal (2013)3102 of 22/05/2013